We are live on ! Find out more
MBOT icon

Microbot Medical

30 hedge funds and large institutions have $5.19M invested in Microbot Medical in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

9% less funds holding

Funds holding: 3330 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

53% less capital invested

Capital invested by funds: $11.1M → $5.19M (-$5.86M)

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
13
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q2 2015 in Review

30 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2015, worth a combined $5.19M — down 53% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MBOT and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 13 added.

The largest buyer was Vanguard Group, adding an estimated $589K. The largest seller was Sabby Management, cutting an estimated $1.85M.

  • 30 institutional investors held Microbot Medical (MBOT) as of Q2 2015, down from 33 in Q1 2015.
  • Funds reported $5.19M of Microbot Medical stock for Q2 2015, down 53% quarter-over-quarter.
  • 4 funds opened new Microbot Medical positions in Q2 2015 and 7 closed out, a net change of -3 holders.
  • The largest Microbot Medical buyer in Q2 2015 was Vanguard Group, an estimated $589K added.
  • The largest Microbot Medical seller in Q2 2015 was Sabby Management, an estimated $1.85M sold.

Based on aggregated 13F filings for Q2 2015.